Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data.

Andrea MarcellusiRaffaella VitiLoreta A KondiliStefano RosatoStefano VellaFrancesco Saverio Mennininull null

Published in: PharmacoEconomics (2020)

This study may be a useful tool for public decision makers to understand how HCV clinical and epidemiological profiles influence the economic burden of HCV.

Keyphrases

hepatitis c virus
human immunodeficiency virus
healthcare
mental health
patient safety
electronic health record
emergency department
replacement therapy
deep learning
smoking cessation